Journal of Developing Drugs

Journal of Developing Drugs
Open Access

ISSN: 2329-6631

+44 7868 792050

Editorial Board

Yavuz S Silay, Ms, Phd
Director, Therapeutic Medical Head, Teva Neurosciences Commercial Organization
Hampton University, USA

Walter J Lukiw
Executive Editor
Associate Professor, Department of Ophthalmology
Louisiana State University, USA

Ritu Aneja
Executive Editor
Associate Professor, Department of Biology
Georgia State University, USA

Submit Manuscript

Submit manuscript at Online Submission System or send as an e-mail attachment to the Editorial Office at

Table of Contents

About the Journal

Impact Factor: 0.67;  NLM ID: 101646699; Index Copernicus Value: 62.16 

Journal of Developing Drugs is at higher echelons that enhance the intelligence and information dissemination on topics closely related to Developing Drugs.The Journal provides a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on an array of Journal of Developing Drugs Research.

The Developing Drugs Peer Reviewed Journals are proficiently supported by universally prominent Editorial Board members. Developing Drugs journal Impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Developing Drugs Open Access Journals are freely accessible to everyone immediately after publication.

Journal of Developing Drugs under Open Access platform focuses on pharmaceuticals coming up through the pipeline and thus aims to advance our understanding of the action of drugs, their harmful effects, prevention and treatment of both existing as well as emerging diseases.

The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing. Journal of Developing Drugs is one of the best Open Access journals of Scholarly publication.

This Pharmaceutical Science Journal adapts to Editorial Manager System for quality in review process. The review process is performed by the editorial board members of Journal of Developing Drugs or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Authors can submit their manuscripts through online link  Online Submission System  or send as an e-mail attachment to the Editorial office 

Fast Editorial Review Process

Journal of Developing Drugs is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.


Articles published in Journal of Developing Drugs have been cited by esteemed scholars and scientists all around the world. Journal of Developing Drugs has got h-index 17 , which means every article in Journal of Developing Drugs has got 17 average citations.

Journal Highlights

Relevant Topics